NCT00723086View on ClinicalTrials.gov

Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Therapy, Prostatic Neoplasms
Interventions
DRUG

docetaxel (XRP6976)

combined treatment with prednisolone

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY